Your  Account:

Instutitional Biosafety Committee

California State University, San Marcos (CSUSM) established an Institutional Biosafety Committee (IBC) under the authority of the Office of the President.

The policies of CSUSM follow guidelines and regulations set forth by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the United States Department of Agriculture (USDA), the Environmental Protection Agency (EPA) and the California Occupational Safety and Health Administration (Cal-OSHA).

The IBC establishes, monitors, and enforces CSUSM policies and procedures, which meet or exceed applicable norms or regulations for biohazardous materials and/or recombinant DNA.

  • Specifically, reviewing and approving research projects involving recombinant or synthetic nucleic acid molecule research or any other research that relates to Select Agents and toxins; Xenotransplantation; Stem Cell research; “Dual Use” research; and Nanotechnology, conducted at or sponsored by the institution for compliance with the NIH Guidelines.

Most importantly, the IBC’s objective is to ensure that such activities meet standards of good biological safety practices, emphasizing protection of personnel, the public, and the environment. 

Submit a Biological Use Application.

Submit a Biological Use Continuation Form.

IBC Email Address
Messages are directed to the Office of Graduate Studies and Research and the IBC Chair.

Institutional Officer (IO)
Dr. Charles De Leone, Dean
Office of Graduate Studies and Research